Short Interest in Sartorius Stedim Biotech S.A. (OTCMKTS:SDMHF) Decreases By 19.4%
by Kim Johansen · The Markets DailySartorius Stedim Biotech S.A. (OTCMKTS:SDMHF – Get Free Report) saw a significant decline in short interest in December. As of December 15th, there was short interest totalling 57,500 shares, a decline of 19.4% from the November 30th total of 71,300 shares. Based on an average trading volume of 100 shares, the short-interest ratio is currently 575.0 days.
Sartorius Stedim Biotech Stock Performance
OTCMKTS SDMHF remained flat at $195.00 during trading hours on Friday. 139 shares of the company traded hands, compared to its average volume of 1,306. Sartorius Stedim Biotech has a twelve month low of $158.00 and a twelve month high of $299.86. The company’s 50 day moving average price is $193.79 and its 200-day moving average price is $190.64.
About Sartorius Stedim Biotech
Sartorius Stedim Biotech SA engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products.
See Also
- Five stocks we like better than Sartorius Stedim Biotech
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Power Up: Gaming Industry Expansion Fuels Stock Opportunities
- 3 REITs to Buy and Hold for the Long Term
- These 3 Quirky ETFs May Be Strong Plays in 2025
- 3 Fintech Stocks With Good 2021 Prospects
- Buffett Takes the Bait; Berkshire Buys More Oxy in December